9th time Union budget by Nirmala Sitaraman as Finance minister shows Mixed but Strategic Approach.
Today’s Budget clearly places healthcare at the centre of India’s growth narrative — with initiatives aimed at expanding infrastructure, strengthening domestic manufacturing, and enhancing access and affordability. Key moves include:
- A ₹10,000 crore “Biopharma Shakti” programme to boost domestic biopharmaceutical innovation and production — particularly for biologics and advanced therapies.
- Waiver of customs duty on 17 cancer drugs and exemptions for medicines targeting seven rare diseases to lower treatment costs.
- Expansion of mental health facilities (e.g., NIMHANS 2.0) and emergency/trauma care.
- Strong push to medical tourism via five regional hubs combining modern care with traditional treatments.
For many healthcare practitioners, these measures signal broader recognition of the health sector’s role in economic stability, research, workforce growth, and service availability.
AYUSH & Homoeopathy — Recognition but Limited Direct Budget Allocation said Dr. A.K.Gupta.
One of the most discussed aspects from an AYUSH and homoeopathy angle is the focus on traditional and integrative healthcare:
Budget Direction on AYUSH
- The Budget proposes five regional AYUSH medical hubs that integrate traditional systems (Ayurveda, Yoga, Unani, Homoeopathy, Siddha) with diagnostics and rehab infrastructure.
- Three All India Institutes of Ayurveda are to be established; allied health disciplines expanded to train allied professionals like caregivers, optometrists, psychologists etc.
- There’s a general push tostrengthen AYUSH-led services and employability within the medical tourism framework.
What IS NOT Clearly Highlighted for Homoeopathy
From available budget texts and announcements:
No specific line-item increase or new programme exclusively for homoeopathy was announced in the main Budget speech today. Budget communication instead lumps Homoeopathy under the overall AYUSH framework without detailed separate funding commitments in the headline Budget speech or documents laments Dr. Gupta.
In the Spirit of HMAI, One Profession. One Voice. One Future.
Although the AYUSH ministry handles homoeopathy (e.g., via the National Commission for Homoeopathy and related research councils), today’s Budget did not explicitly highlight enhanced finances or targeted schemes for homoeopathic education, research, or clinical services in the same way as biopharma, mental health, or allied training.
Interpretation for Homoeopathy Practitioners:
The government’s intent to expand “integrated care hubs” and strengthen the AYUSH ecosystem provides a platform for homoeopathy to be involved in a broader healthcare delivery network. However, specific incentives, research funding, insurance coverage expansion, or dedicated operational support for homoeopathy are not prominently articulated in the initial Budget rollout — which may feel underwhelming for practitioners seeking direct sectoral prioritization.
Protecting the Profession, Empowering the Practioners.
Practitioner-Level Implications & Opportunities
Here’s how the Budget provisions could be interpreted pragmatically from a homoeopathy practitioner’s viewpoint:
Positive Signals
✔ Recognition of AYUSH in mainstream healthcare: The creation of integrative medical hubs and targeted workforce training expands space for traditional systems (including homoeopathy) to collaborate in patient care frameworks.
✔ Medical tourism focus may open new practice and referral pathways that include calibrated AYUSH therapies alongside allopathic care.
✔ Allied health training and caregiver upskilling could indirectly benefit clinics that adopt multi-modal care approaches, enhancing employability and service delivery.
Areas of Concern or Unfulfilled Expectations
✖ Lack of explicit homoeopathy research support: Budget did not highlight dedicated funding to strengthen clinical research or evidence-generation for homoeopathy — a long-standing demand among practitioners seeking scientific validation.
✖ Insurance and reimbursement gaps remain: Unless AYUSH treatments (including homoeopathy) are formally expanded within national insurance schemes like Ayushman Bharat, practitioners will still face limitations in patient affordability and mainstream coverage.
✖ Operational clarity missing: Details on how homoeopathic units or research bodies will participate in medical hubs, or whether they’ll receive specific programmatic budgets, are not yet clear from the initial Budget statements.
Practitioner Perspective
DimensionBudget PositionRelevance for Homoeopathy PractitionersGovernment healthcare focusStrong (biopharma, tertiary care, mental health)Limited direct linkageAYUSH prominenceModerate — integrated hubs, allied trainingOpportunity for inclusion, but generalHomoeopathy specific fundingNot emphasizedPractitioner disappointment likelyResearch and clinical evidence supportNot highlightedKey gap for sector growthInsurance & reimbursementNot detailedContinues to be a systemic challenge.
Final Assessment
Today’s Union Budget 2026 reflects a forward-looking healthcare blueprint that invests in infrastructure, medical tourism, and national research ecosystems — but for homoeopathy practitioners, it falls short of clear, targeted support or fiscal incentives. While the inclusion of homoeopathy within broader AYUSH expansion and integrated medical hubs is a positive recognition, the lack of dedicated research funds, insurance coverage mandates, and explicit operational roles in major programmes may leave many in the homoeopathic community feeling that their sector’s potential is acknowledged but not yet fully harnessed.
For Ethics, Excellence & Unity in Homoeopathy
Dr.A.K.Gupta MD (Hom)
Secretary General – The Homoeopathic Medical Association of India (HMAI)
Founder Director AKGsOVIHAMS ( Om Vidya Institute of Homoeopathy and Allied Medical Sciences)
Father of Integration in Medicine and Healthcare.
M – 7011842322
Email – drakgupta@ovihams. Com
